SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 340.98 |
| Enterprise Value ($M) | 248.48 |
| Book Value ($M) | 83.68 |
| Book Value / Share | 5.58 |
| Price / Book | 4.07 |
| NCAV ($M) | 79.07 |
| NCAV / Share | 5.27 |
| Price / NCAV | 4.31 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.74 |
| Return on Assets (ROA) | -0.58 |
| Return on Equity (ROE) | -0.67 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 7.61 |
| Current Ratio | 7.61 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 94.81 |
| Assets | 99.41 |
| Liabilities | 15.73 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
| 13G/A | Soleus Private Equity Fund III, L.P. | 9.00 | ||
| 13G | BlackRock, Inc. | 5.30 | 0.00 | |
| 13G/A | Sphera Funds Management Ltd. | 1.25 | ||
| 13G/A | Qiming U.S. Healthcare Fund II, L.P. | 6.20 | ||
| 13D/A | Velan Capital Investment Management LP | 9.80 | ||
| 13G/A | Soleus Capital Master Fund, L.P. | 8.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,472 | 133,080 | 11.63 | |
| 23,443 | 96,393 | 24.32 | |
| 16,672 | 87,566 | 19.04 | |
| 35,510 | 149,344 | 23.78 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IRD – Opus Genetics, Inc. | ITRM – Iterum Therapeutics plc |
| JAGX – Jaguar Health, Inc. | KALA – KALA BIO, Inc. |
| KPRX – Kiora Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io